Literature DB >> 24379184

Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney.

Jennifer J DuPont1, Michael A Hill, Shawn B Bender, Frederic Jaisser, Iris Z Jaffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24379184      PMCID： PMC3954941          DOI： 10.1161/HYPERTENSIONAHA.113.01273

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  68 in total

1.  Distinguishing the antihypertensive and electrolyte effects of eplerenone.

Authors:  D G Levy; R Rocha; J W Funder
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 2.  Central serous chorioretinopathy: an update on pathogenesis and treatment.

Authors:  M Gemenetzi; G De Salvo; A J Lotery
Journal:  Eye (Lond)       Date:  2010-10-08       Impact factor: 3.775

Review 3.  Role of epithelial sodium channels and their regulators in hypertension.

Authors:  Rama Soundararajan; David Pearce; Rebecca P Hughey; Thomas R Kleyman
Journal:  J Biol Chem       Date:  2010-07-12       Impact factor: 5.157

4.  Eplerenone in patients with systolic heart failure and mild symptoms.

Authors:  Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

Review 5.  Large conductance, Ca2+-activated K+ channels (BKCa) and arteriolar myogenic signaling.

Authors:  Michael A Hill; Yan Yang; Srikanth R Ella; Michael J Davis; Andrew P Braun
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

Review 6.  Altered Ca-dependent fluxes of 42K in rat aorta during aldosterone-salt hypertension.

Authors:  A W Jones; J M Smith
Journal:  Prog Clin Biol Res       Date:  1986

7.  The role of aldosteronism in causing obesity-related cardiovascular risk.

Authors:  David A Calhoun; Kumar Sharma
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

8.  The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cells.

Authors:  Min Zhao; Fatemeh Valamanesh; Isabelle Celerier; Michèle Savoldelli; Laurent Jonet; Jean-Claude Jeanny; Frederic Jaisser; Nicolette Farman; Francine Behar-Cohen
Journal:  FASEB J       Date:  2010-05-13       Impact factor: 5.191

9.  Aldosterone infusion into the rat and dose-dependent changes in blood pressure and arterial ionic transport.

Authors:  E T Garwitz; A W Jones
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

10.  Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure.

Authors:  Mark S Taylor; Adrian D Bonev; Tobias P Gross; Delrae M Eckman; Joseph E Brayden; Chris T Bond; John P Adelman; Mark T Nelson
Journal:  Circ Res       Date:  2003-06-12       Impact factor: 17.367
View more
  20 in total

1.  Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension.

Authors:  Janice M Diaz-Otero; Ting-Chieh Yen; Courtney Fisher; Daniel Bota; William F Jackson; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-17       Impact factor: 4.733

Review 2.  Vasodysfunction That Involves Renal Vasodysfunction, Not Abnormally Increased Renal Retention of Sodium, Accounts for the Initiation of Salt-Induced Hypertension.

Authors:  R Curtis Morris; Olga Schmidlin; Anthony Sebastian; Masae Tanaka; Theodore W Kurtz
Journal:  Circulation       Date:  2016-03-01       Impact factor: 29.690

Review 3.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

4.  Aldosterone impairs coronary adenosine-mediated vasodilation via reduced functional expression of Ca2+-activated K+ channels.

Authors:  Maloree Khan; Alex I Meuth; Scott M Brown; Bysani Chandrasekar; Douglas K Bowles; Shawn B Bender
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-14       Impact factor: 4.733

Review 5.  The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.

Authors:  Amanda J Miller; Amy C Arnold
Journal:  Clin Auton Res       Date:  2018-11-09       Impact factor: 4.435

Review 6.  Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift.

Authors:  L H White; T D Bradley; A G Logan
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

Review 7.  Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.

Authors:  Guanghong Jia; Annayya R Aroor; Michael A Hill; James R Sowers
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

8.  Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature.

Authors:  Scott M Brown; Alex I Meuth; J Wade Davis; R Scott Rector; Shawn B Bender
Journal:  Pharmacol Res       Date:  2018-06-02       Impact factor: 7.658

Review 9.  Is there a new dawn for selective mineralocorticoid receptor antagonism?

Authors:  James M Luther
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-09       Impact factor: 2.894

Review 10.  Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis.

Authors:  Elise P Gomez-Sanchez
Journal:  Steroids       Date:  2014-12       Impact factor: 2.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.